Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Little

Showing results (111-120 of 185) with videos related to

Pageof 19
Sort By:
Cellular Signalling|November 10, 2015
Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genesDanielle Kamato, Lyna Thach, Robel Getachew, et al.
Journal of Cardiovascular Pharmacology|March 22, 2008
Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesisPeter J Little, Mandy L Ballinger, Soniya Survase, et al.
Trends in Pharmacological Sciences|July 28, 2022
Mouse models of atherosclerosis in translational researchIqra Ilyas, Peter J Little, Zhiping Liu, et al.
International Journal of Molecular Sciences|November 26, 2022
Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle CellsDanielle Kamato, Mai Gabr, Hirushi Kumarapperuma, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein bindingMandy L Ballinger, Narin Osman, Andrew F Wilks, et al.
The Journal of Pharmacy and Pharmacology|December 2, 2016
Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesisNarges Sharifat, Ghorban Mohammad Zadeh, Mohammad-Ali Ghaffari, et al.
Endocrinology|January 22, 2005
Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein bindingKazuhiko Hashimura, Krishnankutty Sudhir, Julie Nigro, et al.
Cellular Signalling|November 14, 2018
Individual Smad2 linker region phosphorylation sites determine the expression of proteoglycan and glycosaminoglycan synthesizing genesDanielle Kamato, Micah Burch, Ying Zhou, et al.
Clinical and Experimental Pharmacology & Physiology|November 8, 2014
Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular diseaseMuhamad A Rostam, Terrence J Piva, Hossein B Rezaei, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|September 25, 2012
Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycansNarin Osman, K Jane Grande-Allen, Mandy L Ballinger, et al.
Pageof 19

Showing results (111-120 of 185) with videos related to

Sort By:
Pageof 19
Cellular Signalling|November 10, 2015
Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genesDanielle Kamato, Lyna Thach, Robel Getachew, et al.
Journal of Cardiovascular Pharmacology|March 22, 2008
Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesisPeter J Little, Mandy L Ballinger, Soniya Survase, et al.
Trends in Pharmacological Sciences|July 28, 2022
Mouse models of atherosclerosis in translational researchIqra Ilyas, Peter J Little, Zhiping Liu, et al.
International Journal of Molecular Sciences|November 26, 2022
Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle CellsDanielle Kamato, Mai Gabr, Hirushi Kumarapperuma, et al.
Journal of Cardiovascular Pharmacology|November 27, 2008
Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein bindingMandy L Ballinger, Narin Osman, Andrew F Wilks, et al.
The Journal of Pharmacy and Pharmacology|December 2, 2016
Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesisNarges Sharifat, Ghorban Mohammad Zadeh, Mohammad-Ali Ghaffari, et al.
Endocrinology|January 22, 2005
Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein bindingKazuhiko Hashimura, Krishnankutty Sudhir, Julie Nigro, et al.
Cellular Signalling|November 14, 2018
Individual Smad2 linker region phosphorylation sites determine the expression of proteoglycan and glycosaminoglycan synthesizing genesDanielle Kamato, Micah Burch, Ying Zhou, et al.
Clinical and Experimental Pharmacology & Physiology|November 8, 2014
Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular diseaseMuhamad A Rostam, Terrence J Piva, Hossein B Rezaei, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|September 25, 2012
Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycansNarin Osman, K Jane Grande-Allen, Mandy L Ballinger, et al.
Pageof 19